The only clinically proven, FDA Authorized lenses for migraine light sensitivity.

Manage the Impact of Light on Your Life

Avulux is intended to decrease the impact of light sensitivity in people with episodic migraine aged 12+, alongside your usual migraine care. Full Indications

Reader Migraine Glasses

New Avulux Adapt and Avulux Atlas lenses now available.
Click into your favorite frames to learn more.

Looking for different frames to suit your style?

Avulux Authorized Providers offer a wide frame selection and prescription and non-prescription Avulux lens options.

Visit an Avulux Authorized Provider

Find Daily Comfort

90% of wearers find Avulux helps them through their days.

Patented Lenses

Avulux technology filters harmful blue, amber, and red light - unlike any other lens.

60-Day Returns

Experience the benefits of Avulux at your own pace.

Over 50,000 Happy Avulux Wearers

See what people have to say.

Trusted by 1,400+ Health Care Providers Globally

Find a provider near you.

60-Day Returns

60 day returns on non-custom items so you can be sure you're happy with Avulux glasses. Read policy.

Customer Success

Questions, comments, or just need Help? Contact us.

Visit an Avulux Authorized Provider

Find Avulux Provider

Visit ECP Site

Indications for Use: Avulux® is an FDA-authorized, over-the-counter precision optical filter indicated to block light at 480 nm (high blue range) and 590 nm (red/amber range), while allowing light in the remaining visible color spectrum through, to decrease the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older. The use of Avulux should not alter the usual care therapy of patients diagnosed with episodic migraine, including medication usage.

Avulux is intended to be used as an adjunct to usual care for migraine, including medication. It is not intended to diagnose, treat, cure, or prevent migraine or any other disease and is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare professional regarding migraine symptoms and treatment. Avulux is classified by the U.S. Food and Drug Administration as a Class I medical device under 21 CFR § 882.5811, product code QEO. De Novo request DEN250026.